Asthma Watch: Trelegy Ellipta Hits Phase 3 Asthma Marks, Eyes New Indication
August 22nd 2019Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.
Asthma Watch: Traffic-Related Air Pollution Causes Asthma for Millions of Children
August 22nd 2019The results of a new study by George Washington University show that about 4 million children worldwide develop asthma annually because of nitrogen dioxide inhalation through air pollution.